Group 1 - The board of directors of Guizhou Yibai Pharmaceutical Co., Ltd. held its 15th meeting of the 8th session on November 26, 2025, to address urgent matters, waiving the notice period as per company regulations [2][5] - All 7 directors attended the meeting, which was chaired by Chairwoman Dou Qiling [3][4] - The meeting was compliant with the Company Law and the company's articles of association [5] Group 2 - The board approved the proposal to supplement the independent director position, following the resignation of independent director Chen Yisong due to personal reasons [6] - Liang Liang was elected as the new independent director and will also serve as the chair of the audit committee, a member of the nomination committee, and a member of the remuneration and assessment committee [6] - Liang Liang holds a PhD in management from Tohoku University, Japan, and is currently an associate professor at Guizhou University, with no prior shareholding in the company [8]
贵州益佰制药股份有限公司 第八届董事会第十五次会议决议公告